International Organization For the Study of Inflammatory Bowel Disease

The International Organization for the Study of Inflammatory Bowel Diseases (IOIBD) is the only international worldwide organization devoted to these chronic and sometimes disabling diseases involving different parts of the gastrointestinal tract. The mission of the IOIBD is to promote the health of people with IBD worldwide by setting the direction for patient care, education and research. This is in particular the case for those countries where the diseases are just evolving. Task forces of IOIBD promote scientific developments by designing non commercial clinical studies. Grants are provided for innovative start-up projects and large scale trials not receiving funds otherwise due to lack of economic or political interest. Travel grants are given to young scientists from countries with evolving IBD. The organization furthermore aims at developing clear definitions of the different manifestations of IBD as well as for the targets and endpoints of treatment in practice and research, in particular in clinical trials.

The long-term goal of IOIBD is to contribute to the elucidation of the cause of these still relatively new diseases and finally to the development of a causal and curative treatment, thereby making its existence unnecessary.

Mission Statement
To promote the health of people with IBD worldwide by setting the direction for patient care, education and research.

Upcoming meetings:
Thursday 15- Sunday 18 March 2018, Rio de Janeiro (Brazil)
Spring 2019, Havana (Cuba)
Spring 2020, HongKong (China)

___________________________________________________________________________


           Announcement 26 April 2017

   http://mdxvitals-res.cloudinary.com/private_images/h_1200,w_1200,c_thumb,f_auto,q_auto,dpr_auto/professionals/1754461/Dr_Adrian_Greenstein.jpg

It is with deep sadness that we share the passing of Adrian Greenstein, MD, FACS, FRCS, a beloved colleague and friend, and a Professor of Surgery at the Icahn School of Medicine at Mount Sinai since 1968. He built a career operating on the most difficult cases—those most surgeons would avoid—and in the process established himself as a world-renowned expert on inflammatory bowel disease (IBD). Until recently, Dr. Greenstein maintained the busiest complex IBD surgical practice in New York City.

Often, high-caliber surgeons like Dr. Greenstein are primarily known for their technical skills. However, his expertise was a step beyond the rest due to his diligent tracking of patient outcomes, a subject on which he published an impressive array of research papers. Dr. Greenstein’s clinical investigations, and more than 160 papers and 30 chapters, served as guides to practically every aspect of surgical management of patients with colorectal conditions. In essence, when clinicians cite the “Mount Sinai experience” in regards to the surgical management of IBD, Dr. Greenstein’s work is quoted.  He truly established Mount Sinai’s Department of Surgery as a major force in the management of complicated colorectal surgical conditions.

In addition to his research and teaching accomplishments, Dr. Greenstein was a marvelous physician. Possessing a legendary bedside manner, he was adored by patients and colleagues.  Generations of residents and medical students were fortunate to be trained by such a well-rounded physician. As further proof of his remarkable impact on the Mount Sinai community, Dr. Greenstein won the 2011 John H. Garlock Award (Medal), which recognizes “outstanding service to the Mount Sinai Department of Surgery over the course of a career.”

Dr. Greenstein received his medical degree from the University of Witwatersrand in Johannesburg. He completed his postgraduate training as a surgeon in the United Kingdom and became a fellow of both the Royal College of Surgeons of Edinburgh and England. He went on to complete his residency at Boston University in 1968, after which he joined the Mount Sinai Medical Center as a member of the full-time faculty.

Michael L. Marin, MD                                            
The Jacobson Professor of Surgery
Chairman, Department of Surgery
Icahn School of Medicine at Mount Sinai
Surgeon-In-Chief
Mount Sinai Health System

Kenneth L. Davis, MD
President and Chief Executive Officer
Mount Sinai Health System

Dennis S. Charney, MD
Anne and Joel Ehrenkranz Dean
Icahn School of Medicine at Mount Sinai
President for Academic Affairs
Mount Sinai Heath System

We extend our deepest condolences to his entire family, including his son and our colleague, Alexander J. Greenstein, MD, Associate Professor, Surgery, Icahn School of Medicine at Mount Sinai.

 

 

Comments are closed.

Contact IOIBD       |       Webdesign Inmedia